Herein, we employed clinically approved HSA as the carrier to encapsulate photosensitizer Chlorin e6 (Ce6) via well-defined precipitation inside albumin nanocage for targeted delivery of Ce6 and potent PDT effect against murine bladder cancer and restricted human bladder tumor tissue. The gene discussed is ALB; the disease is urinary bladder carcinoma.